Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress

Molecular Carcinogenesis

Volumn 24, Issue 1, 1999, Pages 15-24

  Yin, Yuxin ^a,b,d   Solomon, Gregory ^a   Deng, Chuxia ^c   Barrett, J Carl ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

Apotosis; Oxidative stress; P21; P53; Rb

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; ESTRADIOL; HYDROGEN PEROXIDE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOHEXIMIDE; ENZYME INHIBITORS; ESTRADIOL; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032940947     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199901)24:1<15::AID-MC3>3.0.CO;2-Y     Document Type: Article

References (69)

1. Nakano M. Free radicals and their biological significance: Present and future. Hum Cell 1992;5:334-340.
2. Cochrane CG. Cellular injury by oxidants. Am J Med 1991;91: 23-30.
3. Adams JD, Mukherjee SK, Klaidman LK, Chang ML, Yasharel R. Apoptosis and oxidative stress in the aging brain. Ann N Y Acad Sci 1996;786:135-151.
4. Ratan RR, Baraban JM. Apoptotic death in an in vitro model of neuronal oxidative stress. Clin Exp Pharmacol Physiol 1995;22:309-310.
5. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
6. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1994;362:847-849.
7. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-852.
8. Yonish Rouach E, Resnitzky D, Lotem J, et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347.
9. Caelles C, Helmberg A, Kann M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994;370:220-223.
10. Wagner AJ, Kokontis JM, Hay N. Myc-mediated p53 requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 1994;8:2817-2830.
11. Sabbatini P, Lin J, Levine AJ, White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995;9:2184-2192.
12. Yonish Rouach E, Deguin V, Zaitchouk T, et al. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 1995;11:2197-2205.
13. Sundaresan M, Yu ZX, Ferrans VJ, et al. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 1996;318:379-382.
14. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA 1996;93:11848-11852.
15. Farmer G, Bargonetti J, Zhu H, et al. Wild-type p53 activates transcription in vitro. Nature 1992;358:83-86.
16. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-83.
17. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;59:1237-1245.
18. Kastan MB, Zhan Q, El Deiry WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587-597.
19. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
20. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-704.
21. El Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
22. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
23. Noda A, Ning Y, Venable SF, Pereira Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-98.
24. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:575-684.
25. Brugarolas J, Chandrasekaran C, Gordon JI, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995;377:552-557.
26. El Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and p53. Cancer Res 1994;54:1169-1174.
27. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716.
28. Lee EY, Chang CY, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haemotopoiesis. Nature 1992;359:288-294.
29. Jacks T, Fazeli A, Schmitt EM, et al. Effects of an Rb mutation in the mouse. Nature 1992;359:295-300.
30. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;371:72-74.
31. Yin Y, Terauchi T, Solomon GG, et al. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 1998;391:707-710.
32. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
33. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992;70:937-948.
34. Almasan A, Yin Y, Kelly RE, et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995;92:5436-5440.
35. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-221.
36. Halbert CL, Demers GW, Galloway DA. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 1991;65:473-478.
37. Chen TM, Chen CA, Hsieh CY, et al. The state of p53 in primary human cervical carcinomas and its effects in human papilloma-virus-immortalized human cervical cells. Oncogene 1993;8:1511-1518.
38. Kern SE, Pietenpol JA, Thiagalingam S, et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992;256: 827-830.
39. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, Second Edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
40. Tommasino M, Crawford L. Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle. Bioessays 1995;17:509-518.
41. Kern SE, Kinzler KW, Bruskin A, et al. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991;252:1708-1711.
42. 3H]tamoxifen to the 8S estradiol receptor. Mol Cell Endocrinol 1978;11:181-198.
43. Yin XM, Oltvai ZN, Korsmeyer SJ. Heterodimerization with Bax is required for Bcl-2 to repress cell death. Curr Top Microbiol Immunol 1995;194:331-338.
44. Henkart PA. ICE family proteases: Mediators of all apoptotic cell death? Immunity 1996;4:195-201.
45. Hockenberry DM. bcl-2, a novel regulator of cell death. Bioessays 1995;17:631-638.
46. Ho YS, Wang YJ, Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 1996;16:20-31.
47. Didenko VV, Wang X, Yang L, Hornsby PJ. Expression of p21(WAF1/CIP1/SDI1) and p53 in apoptotic cells in the adrenal cortex and induction by ischemia/reperfusion injury. J Clin Invest 1996;97:1723-1731.
48. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/ Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332.
49. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
50. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-99.
51. Berry DE, Lu Y, Schmidt B, et al. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene 1996;12:1809-1819.
52. Bing A, Dou QP. Cleavage of retinoblastoma protein during apoptosis: An interleukm 1 beta-converting enzyme-like protease as candidate. Cancer Res 1996;56:438-442.
53. Haas Kogan DA, Kogan SC, Levi D, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995;14:461-472.
54. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991;65:1053-1061.
55. Helin K, Lees JA, Vidai M, et al. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992;70:337-350.
56. Chittenden T, Livingston DM, Kaelin WG Jr. RB associates with an E2F-like, sequence-specific DNA-binding protein. Cold Spring Harb Symp Quant Biol 1991;56:187-195.
57. Nevins JR. E2F:A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-429.
58. Yamasaki L, Jacks T, Bronson R, et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996;85:537-548.
59. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994;91:3602-3606.
60. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996;85:549-561.
61. Weinberg RA. E2F and cell proliferation: A world turned upside down. Cell 1996;85:457-459.
62. Yeager T, Stadler W, Belair C, et al. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 1995;55:493-497.
63. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-261.
64. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 1994;91:5291-5295.
65. Koh J, Enders GH, Dynlacht BD, Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995;375:506-510.
66. Okamoto A, Demetrick DJ, Spillare EA, et al. Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA 1994;:91:11045-11049.
67. Ranade K, Hussussian CJ, Sikorski RS, et al. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 1995;10:114-116.
68. Kern SE, Kinzler KW, Baker SJ, et al. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 1991;6:131-136.
69. Preston GA, Lyon TT, Yin Y, et al. Induction of apoptosis by c-Fos protein. Mol Cell Biol 1996;16:211-218.